Planned Parenthood on DOJ and Manufacturer Seeking Stay in Mifepristone Case at Supreme Court

WASHINGTON D.C. — Today, the Department of Justice announced that they plan to seek emergency relief to block the lower court’s rulings in Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al on the U.S. Food and Drug Administration’s (FDA) approval of mifepristone.

Statement from Planned Parenthood Federation of America President Alexis McGill Johnson: 

“Mifepristone is safe and effective, and it’s critical to ensuring millions of people have access to medication abortion and miscarriage care. The Supreme Court should move swiftly to block the disastrous rulings threatening to undermine the entire FDA’s approval process and authority. Both the very legitimacy of our drug approval system and access to medication abortion are on the line.”

Read Planned Parenthood’s statement on the district court decision blocking the FDA’s approval of mifepristone here, and Planned Parenthood’s statement on the Fifth Circuit’s opinion here.

### 

Planned Parenthood is the nation’s leading provider and advocate of high-quality, affordable sexual and reproductive health care for all people, as well as the nation’s largest provider of sex education. With more than 600 health centers across the country, Planned Parenthood organizations serve all patients with care and compassion, with respect, and without judgment, striving to create equitable access to health care. Through health centers, programs in schools and communities, and online resources, Planned Parenthood is a trusted source of reliable education and information that allows people to make informed health decisions. We do all this because we care passionately about helping people lead healthier lives. Planned Parenthood Federation of America (PPFA) is a 501(c)(3) charitable organization that supports the independently incorporated Planned Parenthood affiliates operating health centers across the U.S.